Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Ovarian Neoplasms

Free Subscription Articles published in Eur J Obstet Gynecol Reprod Biol Retrieve available abstracts of 73 articles: HTML format

Single Articles

May 2026
1. MARYNS AS, Hamerlynck T, van Overberghe C, Allaert E, et al
   Opportunistic salpingectomy: Is surgical completeness achieved? Insights from the QOS study.
   Eur J Obstet Gynecol Reprod Biol. 2026;321:115066.
   PubMed     Abstract available
   
   
   
2. VUPPU DP, Bhati P, Nair IR, Anusree K, et al
   Visual assessment of residual peritoneal disease during interval cytoreductive surgery: a prospective comparison of gross visualisation and laparoscope-assisted techniques.
   Eur J Obstet Gynecol Reprod Biol. 2026;321:115034.
   PubMed     Abstract available
   
   
   April 2026
3. SPAGNOLO E, Hernandez MR, Ferreras ER, Guntinas A, et al
   Impact of endometriosis on survival outcomes in ovarian cancer patients: a pilot study.
   Eur J Obstet Gynecol Reprod Biol. 2026;322:115110.
   PubMed     Abstract available
   
   
   March 2026
4. FUKUDA K, Sakabe N, Sato S, Hara T, et al
   Classification of histological types in ovarian cancer using deep learning.
   Eur J Obstet Gynecol Reprod Biol. 2026;321:115080.
   PubMed     Abstract available
   
   
   
5. BARTIROMO L, Ferrari SM, Schimberni M, Delfanti E, et al
   Neutrophil-To-Lymphocyte and Platelet-To-Lymphocyte Ratios in atypical endometriosis and in Endometriosis-Associated ovarian-Cancer.
   Eur J Obstet Gynecol Reprod Biol. 2026;321:115074.
   PubMed     Abstract available
   
   
   February 2026
6. JIAO Y, Wang D, Sun Z, Su N, et al
   Brenner borderline ovarian tumors: A series of seven cases and a literature review.
   Eur J Obstet Gynecol Reprod Biol. 2026;321:115044.
   PubMed     Abstract available
   
   
   
7. LIANG J, Wu T, Feng X, Jin Y, et al
   Perspective on postoperative hormone replacement therapy and fertility preservation in Swyer syndrome with dysgerminoma: a case series and literature review.
   Eur J Obstet Gynecol Reprod Biol. 2026;317:114857.
   PubMed     Abstract available
   
   
   January 2026
8. GAO X, Jiang X, Chen J, Du B, et al
   Association between cardiometabolic index and prevalence of ovarian cancer among US adults: A cross-sectional NHANES study.
   Eur J Obstet Gynecol Reprod Biol. 2026;319:114954.
   PubMed     Abstract available
   
   
   
9. KESSOUS R, Wiesel O, Dreiher J, Meirovitz M, et al
   High-grade uterine cancer with ambiguous features - a clinicopathological study.
   Eur J Obstet Gynecol Reprod Biol. 2026;318:114952.
   PubMed     Abstract available
   
   
   December 2025
10. HALDER S, Meena J, Singhal S, Kumari R, et al
    Prognostic significance of neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in predicting response to neoadjuvant chemotherapy in advanced high-grade serous ovarian cancer: a prospective study.
    Eur J Obstet Gynecol Reprod Biol. 2025;318:114901.
    PubMed     Abstract available
    
    
    
11. HONG M, Yang K, Ge H, Tang J, et al
    Prognostic factors for ovarian immature teratoma and significance of alpha-fetoprotein in recurrent cases.
    Eur J Obstet Gynecol Reprod Biol. 2025;317:114882.
    PubMed     Abstract available
    
    
    
12. YOONG W, Wylie S, Gahir J, Ho J, et al
    Concurrent vNOTES risk reducing bilateral salpingo-oophorectomy at the time of mastectomy in women with breast cancer and BReast CAncer (BRCA) gene mutation.
    Eur J Obstet Gynecol Reprod Biol. 2025;315:114761.
    PubMed     Abstract available
    
    
    November 2025
13. WONG Y, Fong KY, Lim SK, Nadarajah R, et al
    vNOTES retroperitoneal sentinel lymph node biopsy and pelvic lymph node dissection for surgical staging of endometrial cancer: A single-center experience.
    Eur J Obstet Gynecol Reprod Biol. 2025;316:114838.
    PubMed     Abstract available
    
    
    October 2025
14. DICK A, Lessans N, Cohen N, Gutman-Ido E, et al
    Distinguishing mature from immature ovarian teratoma in the pre-operative setting.
    Eur J Obstet Gynecol Reprod Biol. 2025;316:114793.
    PubMed     Abstract available
    
    
    
15. CASANOVA J, Ramos AS, Babiciu A, Moutinho F, et al
    Prevalence of high-grade endometrioid endometrial cancer of no specific molecular profile (NSMP): A systematic review and meta-analysis.
    Eur J Obstet Gynecol Reprod Biol. 2025;316:114794.
    PubMed     Abstract available
    
    
    
16. SIEGLER Y, Omer A, Yousef Y, Ben David C, et al
    Timing matters: Surgery-to-chemotherapy interval and outcomes in ovarian cancer.
    Eur J Obstet Gynecol Reprod Biol. 2025;315:114772.
    PubMed     Abstract available
    
    
    September 2025
17. CHENG X, Liu P, Zhao Q, Ye L, et al
    Niraparib combined with anlotinib after PARPi resistance in ovarian cancer: A single-center retrospective study from China.
    Eur J Obstet Gynecol Reprod Biol. 2025;314:114707.
    PubMed     Abstract available
    
    
    
18. GARG M, Bhati P, Nair IR, Sheejamol VS, et al
    Delineating the clinico-oncological landscape: Pure Uterine Serous Cancer (P-USC) versus p53 Abnormal Grade 3-Endometrioid-Endometrial Carcinoma (p53 Abn G3-EEC).
    Eur J Obstet Gynecol Reprod Biol. 2025;314:114696.
    PubMed     Abstract available
    
    
    
19. KHASTGIR G, Siwatch S, Singh T, Jain V, et al
    Beyond the Image: Performance of O-RADS, ADNEX, IOTA Simple Rules & RMI 4 in differentiating benign and malignant adnexal masses - An Indian perspective.
    Eur J Obstet Gynecol Reprod Biol. 2025;313:114585.
    PubMed     Abstract available
    
    
    August 2025
20. ROY M, Pace-Loscos T, Schiappa R, Delotte J, et al
    Therapeutic impact of eras protocol implementation in cytoreductive surgery for ovarian cancer.
    Eur J Obstet Gynecol Reprod Biol. 2025;313:114622.
    PubMed     Abstract available
    
    
    July 2025
21. BORIA F, Chiva L, Fernandez-Gonzalez S, Glickman A, et al
    Comparative analysis of Boria's and Suidan's predictive models for complete cytoreduction in advanced ovarian cancer using (18)F-FDG PET/CT.
    Eur J Obstet Gynecol Reprod Biol. 2025;313:114588.
    PubMed     Abstract available
    
    
    June 2025
22. WANG Y, Wang T, Zhou H, Zhang Y, et al
    Oncological and reproductive outcomes of fertility-sparing surgery in young women with early-stage ovarian clear cell carcinoma: A retrospective cohort study.
    Eur J Obstet Gynecol Reprod Biol. 2025;313:114555.
    PubMed     Abstract available
    
    
    
23. ALEXANDER HR, Jain S, Gidwani K, Ulfenborg B, et al
    Novel glycovariant biomarkers of CA125 and CA15-3 and their diagnostic performance across histotypes of ovarian cancer: A multi-cohort study in Sweden and Finland.
    Eur J Obstet Gynecol Reprod Biol. 2025;312:114525.
    PubMed     Abstract available
    
    
    
24. BILLMIRE DF, Turk F, Harris AK, Muraru R, et al
    Surgical staging for ovarian sex cord-stromal tumors: What procedural steps are needed?
    Eur J Obstet Gynecol Reprod Biol. 2025;312:114522.
    PubMed     Abstract available
    
    
    
25. RAY MD, Kapoor R, Banthia P
    The nodal cancer index (NCI): An objective approach for systematic lymph node dissection in ovarian carcinomatosis.
    Eur J Obstet Gynecol Reprod Biol. 2025;312:114113.
    PubMed     Abstract available
    
    
    
26. RAY MD, Kapoor R
    Paraneoplastic syndromes in ovarian carcinoma: A study on clinical spectrum, treatment and survival perspectives.
    Eur J Obstet Gynecol Reprod Biol. 2025;312:114114.
    PubMed     Abstract available
    
    
    
27. LI J, Lu L, Duan J, Gu P, et al
    Fertility-sparing strategies in borderline and malignant ovarian tumors: a comparative analysis of international guideline recommendations.
    Eur J Obstet Gynecol Reprod Biol. 2025;312:114111.
    PubMed     Abstract available
    
    
    May 2025
28. YOONG W, Penny Z, Ho J, Ariyo O, et al
    Outcomes and cost-effectiveness of vNOTES vs conventional laparoscopic ovarian cystectomy for ovarian teratoma (dermoid cysts): A comparison of two minimal access routes of surgery.
    Eur J Obstet Gynecol Reprod Biol. 2025;312:114087.
    PubMed     Abstract available
    
    
    April 2025
29. EINIG S, Puls T, Reina H, Schoetzau A, et al
    External validation of the IOTA two-step strategy in the preoperative characterization of ovarian masses.
    Eur J Obstet Gynecol Reprod Biol. 2025;310:113981.
    PubMed     Abstract available
    
    
    
30. YAO Y, Fu Y
    Comment on: "Sentinel lymph node biopsy in early stage ovarian cancer: A prospective observational study".
    Eur J Obstet Gynecol Reprod Biol. 2025 Apr 6:113963.
    PubMed    
    
    
    March 2025
31. SHI G, Wang C, Lu Y, Zhang P, et al
    Cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy for Pseudomyxoma peritonei originating from ovarian teratomas: A single-center case series and literature review.
    Eur J Obstet Gynecol Reprod Biol. 2025;309:107-112.
    PubMed     Abstract available
    
    
    
32. DITTO A, Fucina S, Chiarello G, Bogani G, et al
    An effective surgical approach to treat obese patients with gynecological disease using a subcutaneous abdominal wall-retraction device to perform low-pressure laparoscopy: A prospective, single-center study.
    Eur J Obstet Gynecol Reprod Biol. 2025;309:55-60.
    PubMed     Abstract available
    
    
    
33. UCCELLA S, Puppo A, Garzon S, Palladino S, et al
    Secondary cytoreductive surgery for ovarian cancer recurrence and first-line maintenance therapy: A multicenter retrospective study.
    Eur J Obstet Gynecol Reprod Biol. 2025;306:160-167.
    PubMed     Abstract available
    
    
    
34. HEDA A, Rajaram S, Bahadur A, Gaurav A, et al
    Sentinel lymph node biopsy in early stage ovarian cancer: A prospective observational study.
    Eur J Obstet Gynecol Reprod Biol. 2025;308:121-126.
    PubMed     Abstract available
    
    
    February 2025
35. DICK A, Cohen N, Flamer Y, Shekel E, et al
    Sonographic features of ovarian malignancies in children and young adults - A case control study.
    Eur J Obstet Gynecol Reprod Biol. 2025;308:112-115.
    PubMed     Abstract available
    
    
    January 2025
36. TAYYAB M, Butt ZA, Kamala KP, Fareeda, et al
    Safety of niraparib-based regimens in patients with ovarian cancer: A systematic review and meta-analysis.
    Eur J Obstet Gynecol Reprod Biol. 2025;307:121-127.
    PubMed     Abstract available
    
    
    
37. BARBIER DE REULLE C, Rebotier M, Chopin N, Rossi L, et al
    Mucinous ovarian carcinoma: Impact of ovarian stimulation, hormonal contraception, and hormone replacement therapy.
    Eur J Obstet Gynecol Reprod Biol. 2025;307:13-20.
    PubMed     Abstract available
    
    
    
38. LIU Y, Wang D, Jia C, Su N, et al
    Clear cell borderline ovarian tumor: A retrospective study and literature review.
    Eur J Obstet Gynecol Reprod Biol. 2025;306:75-80.
    PubMed     Abstract available
    
    
    
39. JARA P, De Pace LA, Pina IB, Carballeira CC, et al
    Recurrence rate and quality of life in women with borderline ovarian tumours, according to surgical approach.
    Eur J Obstet Gynecol Reprod Biol. 2025;306:125-131.
    PubMed     Abstract available
    
    
    
40. NAKAMURA K, Ida N, Hirasawa A, Okamoto K, et al
    CD63 as a potential biomarker for patients with ovarian cancer.
    Eur J Obstet Gynecol Reprod Biol. 2025;306:87-93.
    PubMed     Abstract available
    
    
    December 2024
41. WARD A, Dampali R, Wang W, Bertoni Sclavi S, et al
    Risk factors for venous thromboembolism in patients undergoing neoadjuvant chemotherapy as treatment for ovarian cancer.
    Eur J Obstet Gynecol Reprod Biol. 2024;305:292-297.
    PubMed     Abstract available
    
    
    
42. PIO MAIORANO MF, Loizzi V, Maiorano BA, Cormio G, et al
    Haematological toxicity of PARP inhibitors in advanced ovarian cancer: A systematic review and meta-analysis.
    Eur J Obstet Gynecol Reprod Biol. 2024;305:232-240.
    PubMed     Abstract available
    
    
    October 2024
43. KAPOOR S, Singhal S, Dhamija E, Manchanda S, et al
    Diagnostic performance of ultrasound reporting systems in evaluation of adnexal masses: A prospective observational study.
    Eur J Obstet Gynecol Reprod Biol. 2024;301:186-193.
    PubMed     Abstract available
    
    
    
44. TURATI F, Collatuzzo G, Di Maso M, Negri E, et al
    Fraction of cancers attributable to and prevented by reproductive factors and exogenous hormones use in Italy.
    Eur J Obstet Gynecol Reprod Biol. 2024;301:49-54.
    PubMed     Abstract available
    
    
    September 2024
45. AKSAN A, Boran N, Sinem Duru Coteli A, Ustun Y, et al
    Ultra-radical surgery versus standard-radical surgery for the primary cytoreduction of advanced epithelial ovarian cancer; long-term tertiary center experiences.
    Eur J Obstet Gynecol Reprod Biol. 2024;302:125-133.
    PubMed     Abstract available
    
    
    August 2024
46. AIOB A, Lee KB, Kim SI, Kim NK, et al
    Exploring metastasis and recurrence patterns in low-risk grade 3 endometrial cancer: A multicenter retrospective cohort study.
    Eur J Obstet Gynecol Reprod Biol. 2024;301:154-159.
    PubMed     Abstract available
    
    
    July 2024
47. SCALIA P, Levin G, Lau S
    Pembrolizumab for metastatic squamous cell carcinoma arising from mature teratoma of the ovary: A letter to the editor.
    Eur J Obstet Gynecol Reprod Biol. 2024 Jul 31:S0301-2115(24)00421.
    PubMed    
    
    
    June 2024
48. ABU-ZAID A, Baradwan S, Alyafi M, Al Baalharith M, et al
    Association between polycystic ovary syndrome and the risk of malignant gynecologic cancers (ovarian, endometrial, and cervical): A population-based study from the U.S.A. National Inpatient Sample 2016-2019.
    Eur J Obstet Gynecol Reprod Biol. 2024;299:283-288.
    PubMed     Abstract available
    
    
    
49. MOSS E, Taylor A, Andreou A, Ang C, et al
    British Gynaecological Cancer Society (BGCS) ovarian, tubal and primary peritoneal cancer guidelines: Recommendations for practice update 2024.
    Eur J Obstet Gynecol Reprod Biol. 2024;300:69-123.
    PubMed    
    
    
    
50. PERGIALIOTIS V, Feroussis L, Papadatou K, Vlachos DE, et al
    Diaphragmatic stripping in epithelial ovarian cancer at first diagnosis: Impact on morbidity and survival outcomes.
    Eur J Obstet Gynecol Reprod Biol. 2024;299:225-230.
    PubMed     Abstract available
    
    
    May 2024
51. LEBEAU J, Leung J, Bernard L, Zeng X, et al
    Phlegmasia cerulea dolens - A rare presentation of ovarian malignancy.
    Eur J Obstet Gynecol Reprod Biol. 2024 May 25:S0301-2115(24)00259.
    PubMed    
    
    
    
52. MIAO K, Lv Q, Zhang L, Zhao N, et al
    Discriminative diagnosis of ovarian endometriosis cysts and benign mucinous cystadenomas based on the ConvNeXt algorithm.
    Eur J Obstet Gynecol Reprod Biol. 2024;298:135-139.
    PubMed     Abstract available
    
    
    April 2024
53. HU D, Qian J, Yin F, Wei B, et al
    Evaluation of serum CA125, HE4 and CA724 and the risk of ovarian malignancy algorithm score in the diagnosis of high-grade serous ovarian cancer.
    Eur J Obstet Gynecol Reprod Biol. 2024;297:170-175.
    PubMed     Abstract available
    
    
    
54. GAO Y, Zang L, Ye Y, Ma F, et al
    Immunotherapy combined with targeted therapy in advanced small cell carcinoma of the ovary of hypercalcemic type: A case of overall survival lasting for over 5 years.
    Eur J Obstet Gynecol Reprod Biol. 2024 Apr 6:S0301-2115(24)00168.
    PubMed     Abstract available
    
    
    March 2024
55. NATARAJAN P, Martha Schofield A, Elena Vinturache A, Ruthven S, et al
    A comparison of the clinical and histological appearances after treatment of advanced stage ovarian cancer with PlasmaJet(R) device.
    Eur J Obstet Gynecol Reprod Biol. 2024;296:311-315.
    PubMed     Abstract available
    
    
    
56. GUZEL D, Terek C, Besler A, Serin G, et al
    PURE vs. mixed clear cell ovarian carcinomas: Is there any impact on survival?
    Eur J Obstet Gynecol Reprod Biol. 2024;296:321-326.
    PubMed     Abstract available
    
    
    
57. RODOLAKIS I, Liontos M, Pergialiotis V, Haidopoulos D, et al
    Chemotherapy response score as a predictor of survival in ovarian cancer patients.
    Eur J Obstet Gynecol Reprod Biol. 2024;296:233-238.
    PubMed     Abstract available
    
    
    
58. DABI Y, Rockall A, Razakamanantsoa L, Guerra A, et al
    O-RADS MRI scoring system has the potential to reduce the frequency of avoidable adnexal surgery.
    Eur J Obstet Gynecol Reprod Biol. 2024;294:135-142.
    PubMed     Abstract available
    
    
    
59. MALIK N, Sahu B
    Counselling and management of women with genetic predisposition to gynaecological cancers.
    Eur J Obstet Gynecol Reprod Biol. 2024;294:44-48.
    PubMed     Abstract available
    
    
    February 2024
60. BRAUN C, Grunig H, Peikert J, Strobel K, et al
    Do PET-positive supradiaphragmatic lymph nodes predict overall survival or the success of primary surgery in patients with advanced ovarian cancer?
    Eur J Obstet Gynecol Reprod Biol. 2024;296:13-19.
    PubMed     Abstract available
    
    
    
61. GUO L, Kang X, Su Y, Liu X, et al
    Oncologic and reproductive outcomes after fertility-sparing surgery for bilateral borderline ovarian tumors: A retrospective study.
    Eur J Obstet Gynecol Reprod Biol. 2024;296:107-113.
    PubMed     Abstract available
    
    
    
62. SHIBAHARA M, Kurita T, Harada H, Tsuda Y, et al
    Therapeutic management of uterine tumours resembling ovarian sex cord tumours including a focus on fertility: A systematic review.
    Eur J Obstet Gynecol Reprod Biol. 2024;295:1-7.
    PubMed     Abstract available
    
    
    January 2024
63. KATSANEVAKIS E, Addo-Yobo W, Bharathan B, Loona A, et al
    Is routine gastrointestinal endoscopy required in every woman with mucinous ovarian cancer? An analysis of survival rates and metastatic tumours in a cancer centre.
    Eur J Obstet Gynecol Reprod Biol. 2024;294:105-110.
    PubMed     Abstract available
    
    
    
64. NIE X, Xu T, Zhang L, Cheng W, et al
    The Gustave Roussy immune score as a novel scoring system for predicting platinum resistance in advanced high-grade serous ovarian cancer.
    Eur J Obstet Gynecol Reprod Biol. 2024;294:97-104.
    PubMed     Abstract available
    
    
    
65. PETIOT F, Descargues P, Devouassoux-Shisheboran M, You B, et al
    Retrospective analysis of uterine involvement in low grade serous ovarian carcinoma.
    Eur J Obstet Gynecol Reprod Biol. 2024;294:191-197.
    PubMed     Abstract available
    
    
    November 2023
66. LIBERIS A, Kyziridis D, Kalakonas A, Tentes AA, et al
    Cytoreductive surgery and perioperative intraperitoneal chemotherapy in recurrent ovarian cancer: 18 years of experience.
    Eur J Obstet Gynecol Reprod Biol. 2023;292:102-106.
    PubMed     Abstract available
    
    
    
67. LUIS ALCAZAR J, Ramon Perez-Vidal J, Tameish S, Chacon E, et al
    Ultrasound for assessing tumor spread in ovarian cancer. A systematic review of the literature and meta-analysis.
    Eur J Obstet Gynecol Reprod Biol. 2023;292:194-200.
    PubMed     Abstract available
    
    
    
68. SHARON A, Aiob A, Kais M, Apel-Sarid L, et al
    Detection and dissection of sentinel nodes in endometrial endometrioid cancer with indocyanine green using PinPoint laparoscopy: Analysis of the learning curve.
    Eur J Obstet Gynecol Reprod Biol. 2023;292:91-96.
    PubMed     Abstract available
    
    
    September 2023
69. LEMS E, Leemans JC, Lok CAR, Bongers MY, et al
    Current uptake and barriers to wider use of the International Ovarian Tumor Analysis (IOTA) models in Dutch gynaecological practice.
    Eur J Obstet Gynecol Reprod Biol. 2023;291:240-246.
    PubMed     Abstract available
    
    
    July 2023
70. PENG Y, Ur Rehman Aziz A, Wang Y, Li Q, et al
    Ovarian steroid cell tumour, not otherwise specified: A case report.
    Eur J Obstet Gynecol Reprod Biol. 2023 Jul 28:S0301-2115(23)00300.
    PubMed    
    
    
    April 2023
71. TZANIS AA, Antoniou SA, Zacharoulis D, Ntafopoulos K, et al
    The role of systematic pelvic and para-aortic lymphadenectomy in the management of patients with advanced epithelial ovarian, tubal, and peritoneal cancer: A systematic review and meta-analysis.
    Eur J Obstet Gynecol Reprod Biol. 2023;285:198-203.
    PubMed     Abstract available
    
    
    March 2023
72. MATSUO K, Rau AR, Machida H, Roman LD, et al
    Intraoperative rupture and chemotherapy use in stage I ovarian cancer.
    Eur J Obstet Gynecol Reprod Biol. 2023 Mar 20:S0301-2115(23)00105.
    PubMed    
    
    
    January 2023
73. RALSER DJ, Condic M, Otten LA, Koensgen D, et al
    Evolving treatment landscape of advanced endometrial cancer - A current perspective from a German tertiary referral center for gynecological oncology.
    Eur J Obstet Gynecol Reprod Biol. 2023;282:61-63.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Ovarian Neoplasms is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum